Table 1.

Partial Methylation is Correlated With Elapse of Time Since Diagnosis

Pattern APattern BP
N = 109N = 39
Age (years) at Dx 33.5 ± 12.2 35.7 ± 17.6 .219 
WBC (109/L) 32.5 ± 39.4 48.3 ± 72.5 .231 
Platelets (109/L) 468 ± 352 489 ± 348 .223 
Blasts in BM (%) 2.3 ± 2.6 2.9 ± 3.2 .339 
BM Basophils and Eosinophils (%) 6.1 ± 5.4 6.6 ± 3.4 .261 
Spleen size (cm below costal margin) 2.5 ± 4.3 4.2 ± 5.2 .321 
Time since Dx (months) 13.9 ± 18.5 29.3 ± 33.8 .010 
 Median-7.5 Median-26 
Pattern APattern BP
N = 109N = 39
Age (years) at Dx 33.5 ± 12.2 35.7 ± 17.6 .219 
WBC (109/L) 32.5 ± 39.4 48.3 ± 72.5 .231 
Platelets (109/L) 468 ± 352 489 ± 348 .223 
Blasts in BM (%) 2.3 ± 2.6 2.9 ± 3.2 .339 
BM Basophils and Eosinophils (%) 6.1 ± 5.4 6.6 ± 3.4 .261 
Spleen size (cm below costal margin) 2.5 ± 4.3 4.2 ± 5.2 .321 
Time since Dx (months) 13.9 ± 18.5 29.3 ± 33.8 .010 
 Median-7.5 Median-26 

Clinical parameters and time since diagnosis were compared in pattern B chronic phase samples versus pattern A samples. One hundred nine samples were derived from methylation-pattern A patients; 39 samples from pattern B patients. We incorporated all samples including multiple samples from any particular patient taken in the chronic phase. The clinical parameters (aside from age) relate to the number of samples.

Abbreviations: Dx, diagnosis; WBC, white blood cells.

Close Modal

or Create an Account

Close Modal
Close Modal